4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-22-046487
SVP & Chief Accounting Officer sold 2,006 shares at $4.76 ($9,549)
- SVP & Chief Accounting Officer acquired 165,938 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thomsen Jillian B. SVP & Chief Accounting Officer | 2022-08-15 | Grant or award | +165,938 | 336,865 | D | ||
| Thomsen Jillian B. SVP & Chief Accounting Officer | 2022-08-16 | Sale | −2,006 | $4.76 | $9,549 | 334,859 | D |
| Derivatives | |||||||
| Thomsen Jillian B. SVP & Chief Accounting Officer | 2022-08-15 | Grant or award · Common Stock | +331,875 | 331,875 | D | ||
| Open-market sales · 2,006 sh · avg $4.76 · $9,549 | |||||||
Loading xslF345X03/doc4.xml…